Platelet-based Nanoparticle Therapy for Prostate Cancer

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$999,642.00
Award Year:
2010
Program:
SBIR
Phase:
Phase II
Contract:
N44CO201000119
Agency Tracking Number:
N43CO0800063
Solicitation Year:
2010
Solicitation Topic Code:
NCI
Solicitation Number:
PHS2010-1
Small Business Information
ANDROBIOSYS, INC.
Elm and Carlton Streets, BUFFALO, NY, 14263-
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
193493157
Principal Investigator:
Michael Zwick
Business Contact:
(716) 860-7920
mzwick@androbiosys.com
Research Institution:
n/a
Abstract
The goal of this Phase II proposal is to develop directed energy transfer methods for imaging, tissue ablation and release of therapeutic modalities targeted to the vasculature of prostate cancer. The platform technology is a freeze-dried human platelet (Stasix particles) that contains super paramagnetic iron oxide (SPIO) nanoparticles. The Phase I program showed that SPIO-Stasix particles selectively localize to damaged vasculature in human prostate xenografts on immunocompromised mouse hosts. We propose to further validate the use of human platelet products loaded with iron oxides as delivery vehicles for imaging and therapeutic modalities

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government